Literature DB >> 2125216

RDC8 codes for an adenosine A2 receptor with physiological constitutive activity.

C Maenhaut1, J Van Sande, F Libert, M Abramowicz, M Parmentier, J J Vanderhaegen, J E Dumont, G Vassart, S Schiffmann.   

Abstract

The cDNA of an unidentified recently cloned G protein-coupled receptor, RDC8, has been expressed in Y1 adrenal cells, in dog thyrocytes in primary culture and in Xenopus oocytes. In all these systems this resulted in the activation of adenylyl cyclase and of the cyclic AMP cascade in the absence of any added external signal. However, this physiologically constitutive activator was inhibited by adenosine deaminase and by inhibitors of the adenosine A2 receptor. Cos 7 cells transfected with RDC8 cDNA constructs acquired binding characteristics of an adenosine A2 receptor. Moreover, RDC8 mRNA and adenosine A2 receptors display a very similar distribution in the brain. RDC8 therefore codes for an A2 adenosine receptor. Whether the physiologically constitutive activation of this receptor is entirely explained by endogeneously produced adenosine is as yet unknown.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2125216     DOI: 10.1016/s0006-291x(05)80909-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  59 in total

1.  Immunological identification of A2 adenosine receptors by two antipeptide antibody preparations.

Authors:  T M Palmer; K A Jacobson; G L Stiles
Journal:  Mol Pharmacol       Date:  1992-09       Impact factor: 4.436

2.  Molecular modeling of adenosine receptors. I. The ligand binding site on the A1 receptor.

Authors:  A P IJzerman; P J Van Galen; K A Jacobson
Journal:  Drug Des Discov       Date:  1992

Review 3.  In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors.

Authors:  T M Savarese; C M Fraser
Journal:  Biochem J       Date:  1992-04-01       Impact factor: 3.857

Review 4.  Orphan G protein-coupled receptors (GPCRs): biological functions and potential drug targets.

Authors:  Xiao-long Tang; Ying Wang; Da-li Li; Jian Luo; Ming-yao Liu
Journal:  Acta Pharmacol Sin       Date:  2012-02-27       Impact factor: 6.150

5.  Activation of cyclic AMP-dependent kinase is required but may not be sufficient to mimic cyclic AMP-dependent DNA synthesis and thyroglobulin expression in dog thyroid cells.

Authors:  S Dremier; V Pohl; C Poteet-Smith; P P Roger; J Corbin; S O Doskeland; J E Dumont; C Maenhaut
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

6.  Chemical modification and irreversible inhibition of striatal A2a adenosine receptors.

Authors:  K A Jacobson; G L Stiles; X D Ji
Journal:  Mol Pharmacol       Date:  1992-07       Impact factor: 4.436

Review 7.  Receptor-receptor interactions as an integrative mechanism in nerve cells.

Authors:  M Zoli; L F Agnati; P B Hedlund; X M Li; S Ferré; K Fuxe
Journal:  Mol Neurobiol       Date:  1993 Fall-Winter       Impact factor: 5.590

8.  Selective ligands for rat A3 adenosine receptors: structure-activity relationships of 1,3-dialkylxanthine 7-riboside derivatives.

Authors:  H O Kim; X D Ji; N Melman; M E Olah; G L Stiles; K A Jacobson
Journal:  J Med Chem       Date:  1994-11-11       Impact factor: 7.446

9.  Coupling of a transfected human brain A1 adenosine receptor in CHO-K1 cells to calcium mobilisation via a pertussis toxin-sensitive mechanism.

Authors:  P A Iredale; S P Alexander; S J Hill
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

10.  Stimulation of human umbilical vein endothelial cell proliferation by A2-adenosine and beta 2-adrenoceptors.

Authors:  V Sexl; G Mancusi; S Baumgartner-Parzer; W Schütz; M Freissmuth
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.